Ibrutinib, (S)- is a stereoisomer of ibrutinib, an active pharmaceutical ingredient used in pharmaceutical manufacturing. It is a chemical compound with a complex ring-containing structure and is supplied as a research-grade material.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing Ibrutinib, (S)-?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
(R)-1-(3-(4-Amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)-3-chloropropan-1-one
Pharmaceutical impurity reference standard
Tert-butyl 3-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidine-1-carboxylate
research reagent
Tucatinib
pharmaceutical raw material
Pacritinib
pharmaceutical raw material
D-Pemetrexed disodium
pharmaceutical raw material
Roxatidine acetate hydrochloride
pharmaceutical raw material
PCI-32765 (Racemate)
pharmaceutical raw material
Ibrutinib
pharmaceutical raw material
1-[(3S)-3-[4-amino-3-(4-phenoxyphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]piperidin-1-yl]prop-2-en-1-one
XYFPWWZEPKGCCK-SFHVURJKSA-N
C=CC(=O)N1CCC[C@@H](C1)N2C3=NC=NC(=C3C(=N2)C4=CC=C(C=C4)OC5=CC=CC=C5)N
Sourcing Ibrutinib, (S)-?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.